Wills Eye Hospital
Wills Eye Hospital
Philadelphia, Pennsylvania, United States17 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Electrical Stimulation for the Treatment of Glaucoma | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Active, not recruiting | Not applicable | 2026-10-09 | NCT05626491 | |
| Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Not applicable | 2026-10-07 | NCT07220876 | |
| Use of Preoperative Gas in Eyes With Macula-off Rhegmatogenous Retinal Detachment (RRD) | eye disorder, retinal detachment, retinal disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-10-02 | NCT07855770 | |
| CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME | diabetic macular edema | Active, not recruiting | Phase 3 | 2026-10-02 | NCT07449923 | |
| Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) | Optic Neuropathy, Ischemic, cardiovascular disorder, cranial nerve neuropathy, eye disorder, nervous system disorder, non-arteritic anterior ischemic optic neuropathy, optic nerve disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-10 | NCT07453888 | |
| A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema | diabetic macular edema | Active, not recruiting | Phase 4 | 2026-08-25 | NCT05224102 | |
| Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Visual Impairment, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-08-20 | NCT05844982 | |
| An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Active, not recruiting | Phase 3 | 2026-08-18 | NCT06625398 | |
| Descemet Endothelial Thickness Comparison Trial I | Fuchs | Active, not recruiting | Phase 3 | 2026-08-17 | NCT05289661 | |
| Descemet Endothelial Thickness Comparison Trial II | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Fuchs' endothelial dystrophy, corneal disorder, corneal dystrophy, eye disorder, hereditary disease | Recruiting | Phase 3 | 2026-08-17 | NCT05275972 | |
| Clarifying the Optimal Application of SLT Therapy Trial | eye disorder, glaucoma, ocular hypertension | Recruiting | Phase 3 | 2026-08-14 | NCT04967989 | |
| Neoadjuvant Tebentafusp for Uveal Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Uveal Neoplasms, eye disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, uveal disorder, uveal melanoma | Recruiting | Phase 2 | 2026-06-12 | NCT06414590 | |
| A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Uveal Neoplasms, eye disorder, malignant choroid melanoma, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, uveal disorder, uveal melanoma | Active, not recruiting | Not stated | 2026-05-22 | NCT03941379 | |
| Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-02-11 | NCT06524882 | |
| Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-02-11 | NCT06380517 | |
| A Randomized Trial to Evaluate Sequential vs Simultaneous Patching | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-02-11 | NCT04378790 | |
| Novel Glaucoma Diagnostics | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, eye disorder, glaucoma, glucose metabolism disease, macular degeneration, metabolic disease, ocular hypertension, retinal degeneration, retinal disorder, retinal perforation | Recruiting | Not stated | 2024-08-15 | NCT00286637 |